Therapy-related refractory anemia with ringed sideroblasts in chronic lymphocytic leukemiainvolvement of 3q21 region

Cancer Genetics and Cytogenetics

Volumn 129, Issue 1, 2001, Pages 43-46

  Yac, Münci ^a   Sucak, Gülsan Türköz ^a   Our, Gönül ^b   Haznedar, Rauf ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Department of Pediatric Neurology   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA;

ANEMIA, REFRACTORY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY;

EID: 0034908827     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00423-X     Document Type: Article

References (28)

1. Williams Hematology
2. Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A); Results of a randomized clinical trial on 612 patients
3. Proposals for the classification of the myelodysplastic syndromes
4. High resolution of human chromosomes
5. Comperative analysis of high resolution chromosome techniques for leukemic bone marrow
6. Concurrent diagnosis of chronic lymphocytic leukemia and myelodysplastic syndrome
7. Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome
8. Myelomonocytic leukemia supervening on chronic lymphocytic leukemia
9. Chronic lymphocytic leukemia terminating in acute leukemia
10. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia
11. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia
12. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders
13. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes
14. Chromosome 20 deletions in myeloid malignancies; reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes
15. Translocation t(1;3)(p36;q21) in malignant myeloid stem cell disorders
16. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia; biological and clinical features
17. Leukemia breakpoint region in 3q21 is gene rich
18. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia
19. Cytogenetic and moleculer cytogenetic analysis of B cell chronic lymphocytic leukemia; specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes
20. Perspectives on purine analogues
21. Long term follow up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent
22. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the Group C protocol mechanism of the National Cancer Institute; five-year follow-up report
23. Myelodysplasia occuring after fludarabine treatment for chronic lymphocytic leukemia
24. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy
25. Cladribine for Waldenström's macroglobulinemia
26. The role of fludarabine in haematological malignancies
27. Immunological abnormalities in myelodysplastic syndromes. II. Coexistant lymphoid or plasma cell neoplasms; a report of 20 cases unrelated to chemotherapy